The Impact of a Partially Effective HIV Vaccine on a Population of Intravenous Drug Users in Bangkok, Thailand: A Dynamic Model
暂无分享,去创建一个
[1] T. Mastro,et al. Estimating the number of HIV-infected injection drug users in Bangkok: a capture--recapture method. , 1994, American journal of public health.
[2] J. Kaewkungwal,et al. Survival of AIDS patients in the emerging epidemic in Bangkok, Thailand. , 1996, Journal of acquired immune deficiency syndromes and human retrovirology : official publication of the International Retrovirology Association.
[3] D. Simpson,et al. Mortality rates among opioid addicts in a longitudinal study. , 1987, American journal of public health.
[4] E H Kaplan,et al. A model-based estimate of HIV infectivity via needle sharing. , 1992, Journal of acquired immune deficiency syndromes.
[5] D. D. Des Jarlais,et al. Risk factors and HIV seropositivity among injecting drug users in Bangkok. , 1991, AIDS.
[6] A. Abdul-Quader,et al. Crack use and multiple AIDS risk behaviors. , 1991, Journal of acquired immune deficiency syndromes.
[7] H V Fineberg,et al. Bleach programs for preventing AIDS among i.v. drug users: modeling the impact of HIV prevalence. , 1991, American journal of public health.
[8] R. Anderson,et al. Low-efficacy HIV vaccines: potential for community-based intervention programmes , 1996, The Lancet.
[9] Douglas K Owens,et al. Screening Women of Childbearing Age for Human Immunodeficiency Virus: A Model-Based Policy Analysis , 1993 .
[10] D. D. Des Jarlais,et al. Infection with HIV-1 subtypes B and E in injecting drug users screened for enrollment into a prospective cohort in Bangkok, Thailand. , 1998, Journal of acquired immune deficiency syndromes and human retrovirology : official publication of the International Retrovirology Association.
[11] K. Käll,et al. HIV status and changes in risk behaviour among intravenous drug users in Stockholm 1987-1988. , 1990, AIDS.
[12] G. Orth,et al. Comparative prevalence, incidence and short‐term prognosis of cervical squamous intraepithelial lesions amongst HIV‐positive and HIV‐negative women , 1998, AIDS.
[13] S. Blower,et al. Prophylactic vaccines, risk behavior change, and the probability of eradicating HIV in San Francisco. , 1994, Science.
[14] J. Kahn,et al. Risk behavior for HIV infection in participants in preventive HIV vaccine trials: a cautionary note. , 1997, Journal of acquired immune deficiency syndromes and human retrovirology : official publication of the International Retrovirology Association.
[15] David R. Holtgrave,et al. Cost-effectiveness of post-exposure prophylaxis following sexual exposure to HIV. , 1998 .
[16] D. D. Des Jarlais,et al. HIV testing and sexual behavior among intravenous drug users in Bangkok, Thailand. , 1992, Journal of acquired immune deficiency syndromes.
[17] Ross D. Shachter,et al. A Dynamic HIV-Transmission Model for Evaluating the Costs and Benefits of Vaccine Programs , 1998, Interfaces.
[18] E H Kaplan,et al. Needles that kill: modeling human immunodeficiency virus transmission via shared drug injection equipment in shooting galleries. , 1989, Reviews of infectious diseases.
[19] S. Vermund,et al. HIV Vaccine Development: A Progress Report , 1994, Annals of Internal Medicine.
[20] S. Friedman,et al. AIDS risk reduction and reduced HIV seroconversion among injection drug users in Bangkok. , 1994, American journal of public health.